The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The role of liver biopsy in chronic hepatitis C
Open accessAbstract
The report of the 1997 National Institutes of Health Consensus Development Conference on hepatitis C endorsed pretreatment liver biopsy. We revisit the following questions: Does liver histology help determine the urgency of, and predict the likelihood of response to, antiviral therapy, and can surrogate markers supplant histological assessment? Because the rate of progression of chronic hepatitis C is influenced by baseline histological grade/stage, patients can be stratified into those with moderate to severe hepatitis, who merit imminent therapy, and those with mild hepatitis, in whom therapy can be postponed until more effective/tolerable treatments become available. Less advanced baseline histology has been shown to be an independent predictor of responsiveness to antiviral therapy. Although the predictive value of biopsy is insufficient to withhold therapy from patients with advanced fibrosis, baseline biopsy helps gauge expectations for the outcome of therapy. Reports have been published recently suggesting that laboratory markers can predict distinctions between low-grade fibrosis and therapy-indicating septal fibrosis/cirrhosis. These indices, however, are insufficiently reliable to predict histological distinctions in populations with varying prevalences of fibrosis/cirrhosis or to provide anything more than broad qualitative distinctions, far short of the potential information in a liver biopsy. For most patients, the value of pretreatment liver biopsy outweighs its risks, provides information about the urgency of treatment, and should be retained. Studies to identify noninvasive laboratory markers of histological activity and stage, especially genetic predictors of accelerated disease progression, command a high priority. (Hepatology 2002;36:S152-S160).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
Histological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029
An Algorithm for the Grading of Activity in Chronic Hepatitis C
Bedossa, P., & Poynard, T. (1996) · Hepatology · doi:10.1002/hep.510240201 · Cited by 4,088
Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., & Wollman, J. (1981) · Hepatology · doi:10.1002/hep.1840010511 · Cited by 3,522
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Poynard, T., Marcellin, P., Lee, S. S., Niederau, C., Minuk, G. S., Ideo, G., Bain, V., Heathcote, J., Zeuzem, S., Trepo, C., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)07124-4 · Cited by 2,318
Bedossa, P. (1994) · Hepatology · doi:10.1002/hep.1840200104 · Cited by 2,003
Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa
Davis, G. L., Balart, L. A., Schiff, E. R., Lindsay, K., Bodenheimer, H. C., Perrillo, R. P., Carey, W., Jacobson, I. M., Payne, J., Dienstag, J. L., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212203 · Cited by 1,633
Self-citationImbert-Bismut, F., Ratziu, V., Pieroni, L., Charlotte, F., Benhamou, Y., & Poynard, T. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04258-6 · Cited by 1,433
Peginterferon Alfa-2a in Patients with Chronic Hepatitis C
Zeuzem, S., Feinman, S. V., Rasenack, J., Heathcote, E. J., Lai, M.-Y., Gane, E., O'Grady, J., Reichen, J., Diago, M., Lin, A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432301 · Cited by 1,220
The Natural History of Hepatitis C Virus Infection: Host, Viral, and Environmental Factors
Thomas, D. L., Astemborski, J., Rai, R. M., Anania, F. A., Schaeffer, M., Galai, N., Nolt, K., Nelson, K. E., Strathdee, S. A., Johnson, L., et al. (2000) · JAMA · doi:10.1001/jama.284.4.450 · Cited by 1,073
Adinolfi, L. E., Gambardella, M., Andreana, A., Tripodi, M.-F., Utili, R., & Ruggiero, G. (2001) · Hepatology · doi:10.1053/jhep.2001.24432 · Cited by 1,059
Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey
Cadranel, J.-F., Rufat, P., & Degos, F. (2000) · Hepatology · doi:10.1053/jhep.2000.16602 · Cited by 993
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 910
Hepatitis C: the clinical spectrum of disease.
Hoofnagle, J. H. (1997) · Hepatology · doi:10.1002/hep.510260703 · Cited by 765
EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999
(1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80154-8 · Cited by 700
Mohaghegh, H. (2014) · Journal of Liver · doi:10.4172/2167-0889.1000147 · Cited by 609
The Long–Term Pathological Evolution of Chronic Hepatitis C
Yano, M., Kumada, H., Kage, M., Ikeda, K., Shimamatsu, K., Inoue, O., Hashimoto, E., Lefkowitch, J. H., Ludwig, J., & Okuda, K. (1996) · Hepatology · doi:10.1002/hep.510230607 · Cited by 598
AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection
Sheth, S. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00009-9 · Cited by 583
(1997) · Hepatology · doi:10.1002/hep.510260701 · Cited by 569
Ratio of Serum Aspartate to Alanine Aminotransferase in Chronic Hepatitis Relationship to Cirrhosis
Williams, A. L. B., & Hoofnagle, J. H. (1988) · Gastroenterology · doi:10.1016/s0016-5085(88)80022-2 · Cited by 513
Brunt, E. M. (2000) · Hepatology · doi:10.1002/hep.510310136 · Cited by 502
Wiese, M., Berr, F., Lafrenz, M., Porst, H., & Oesen, U. (2000) · Hepatology · doi:10.1053/jhep.2000.8169 · Cited by 349
Factors predictive of a beneficial response to therapy of hepatitis C
Davis, G. L., & Lau, J. Y. (1997) · Hepatology · doi:10.1002/hep.510260721 · Cited by 325
Mathurin, P., Moussalli, J., Cadranel, J.-F., Thibault, V., Charlotte, F., Dumouchel, P., Cazier, A., Huraux, J.-M., Devergie, B., Vidaud, M., et al. (1998) · Hepatology · doi:10.1002/hep.510270333 · Cited by 302
Pohl, A. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)03830-8 · Cited by 287
Poynard, T., & Bedossa, P. (1997) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1997.00141.x · Cited by 277
EASL International Consensus Conference on Hepatitis C
Marcellin, P. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80366-3 · Cited by 268
The Role of Liver Biopsy in Chronic Hepatitis C
Saadeh, S., Cammell, G., Carey, W. D., Younossi, Z., Barnes, D., & Easley, K. (2001) · Hepatology · doi:10.1053/jhep.2001.20534 · Cited by 258
Shakil, A. O., Conry-Cantilena, C., Alter, H. J., Hayashi, P., Kleiner, D. E., Tedeschi, V., Krawczynski, K., Conjeevaram, H. S., Sallie, R., Bisceglie, A. M. D., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-5-199509010-00002 · Cited by 254
Bonacini, M., Hadi, G., Govindarajan, S., & Lindsay, K. L. (1997) · PubMed · Cited by 250
Noninvasive monitoring of patients with chronic hepatitis C
Fontana, R. J., & Lok, A. S. F. (2002) · Hepatology · doi:10.1053/jhep.2002.36800 · Cited by 195
Fibrosis in Patients with Chronic Hepatitis C: Detection and Significance
Poynard, T., Ratziu, V., Benmanov, Y., Di Martino, V., Bedossa, P., & Opolon, P. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9258 · Cited by 172
Park, G. J., Lin, B. P., Ngu, M. C., Jones, D. B., & Katelaris, P. H. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02172.x · Cited by 171
Clinical guidelines on the management of hepatitis C
Booth, J. C. L., O'Grady, J., & Neuberger, J. (2001) · Gut · doi:10.1136/gut.49.suppl_1.i1 · Cited by 161
Wong, J. B., & Koff, R. S. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-9-200011070-00008 · Cited by 155
Relationship of aminotransferases to liver histological status in chronic hepatitis C.
Haber, M. M., Ab, W., Ad, H., & Reuben, A. (1995) · PubMed · Cited by 149
Noninvasive monitoring of patients with chronic hepatitis C
Fontana, R. J., & Lok, A. S.-F. (2002) · Hepatology · doi:10.1002/hep.1840360708 · Cited by 122
Imperiale, T. F., Said, A. T., Cummings, O. W., & Born, L. J. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02322.x · Cited by 111
Healey, C. J., CHAPMAN, R. W. G., & Fleming, K. A. (1995) · Gut · doi:10.1136/gut.37.2.274 · Cited by 108
Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C
Fontaine, H., Nalpas, B., Poulet, B., Carnot, F., Zylberberg, H., Bréchot, C., & Pol, S. (2001) · Human Pathology · doi:10.1053/hupa.2001.28228 · Cited by 92
AST/ALT Ratio ≥1 Is Not Diagnostic of Cirrhosis in Patients with Chronic Hepatitis C
Reedy, D. W., Loo, A. T., & Levine, R. A. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018888021118 · Cited by 79
Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C
Kaserer, Fiedler, Steindl, Müller, E., Wrba, & Ferenci (1998) · Histopathology · doi:10.1046/j.1365-2559.1998.00413.x · Cited by 78
Kernebeck, T., Lohse, A. W., & Grötzinger, J. (2001) · Hepatology · doi:10.1053/jhep.2001.26632 · Cited by 64
Assy, N., & Minuk, G. Y. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00819-4 · Cited by 62
(2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02324.x · Cited by 62
The need for a consensus agreement on indications of liver transplantation
Bismuth, H. (1994) · Hepatology · doi:10.1002/hep.1840200702 · Cited by 59
Effects of Anisotonic Exposure on Duck Hepatitis B Virus Replication
Offensperger, W., Offensperger, S., Stoll, B., Gerok, W., & Häussinger, D. (1994) · Hepatology · doi:10.1002/hep.1840200102 · Cited by 27
Wali, M., Lewis, S., Hübscher, S. G., Harrison, R. F., Ahmed, M., Elias, E., & Mutimer, D. (1999) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1999.00186.x · Cited by 16
Cited by
Wai, C.-T., Greenson, J. K., Fontana, R. J., Kalbfleisch, J. D., Marrero, J. A., Conjeevaram, H. S., & Lok, A. S.-F. (2003) · Hepatology · doi:10.1053/jhep.2003.50346 · Cited by 4,406
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
Ghany, M. G., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2009) · Hepatology · doi:10.1002/hep.22759 · Cited by 2,973
Castéra, L., Vergniol, J., Foucher, J., Le Bail, B., Chanteloup, E., Haaser, M., Darriet, M., Couzigou, P., & de Lédinghen, V. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.018 · Cited by 2,487
The utility of radiological imaging in nonalcoholic fatty liver disease
Saadeh, S., Younossi, Z. M., Remer, E. M., Gramlich, T., Ong, J. P., Hurley, M., Mullen, K. D., Cooper, J. N., & Sheridan, M. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35354 · Cited by 2,110
Lai, C. L., Ratziu, V., Yuen, M.-F., & Poynard, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15108-2 · Cited by 1,727
Metadata
- Authors
- Dienstag, J. L.
- Venue
- Hepatology
- Published
- 2002-11
- Volume
- 36
- Issue
- Supplement 1
- Pages
- S152-S160
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2094516312
- Cited by
- 373
- References
- 49
- FWCI
- 13.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.